San-Duk Yang

Estimation of Prognostic Marker Genes by Public Microarray Data in Patients with Ovarian Serous Cystadenocarcinoma

J. Han, Hyunseok Park, San-Duk Yang, 2016, Yonsei medical journal.

Epigenetic modification of α-N-acetylgalactosaminidase enhances cisplatin resistance in ovarian cancer

Yun Ju Chae, W. Ju, Jung-Hyuck Ahn, 2017, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

The full-length DNA sequence of Epstein Barr virus from a human gastric carcinoma cell line, SNU-719

Jong-il Kim, Jinha Hwang, Myung-Soo Kang, 2015, Virus Genes.

Clinical decision support algorithm based on machine learning to assess the clinical response to anti-programmed death-1 therapy in patients with non-small-cell lung cancer.

S. Heo, S. Lim, B. Cho, 2021, European journal of cancer.

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

S. Heo, S. Lim, B. Cho, 2022, Therapeutic advances in medical oncology.

Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma

S. Heo, S. Lim, B. Cho, 2021, Clinical Cancer Research.

Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer

A. Park, W. Ju, Jung-Hyuck Ahn, 2016, Yonsei medical journal.

Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer

Sun Wook Cho, Jeong-Sun Seo, Jeongseon Kim, 2017, Nature Communications.

Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer

San-Duk Yang, Woong Ju, W. Ju, 2017, Experimental &Molecular Medicine.

Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib

S. Lim, B. Cho, H. Shim, 2021, JTO clinical and research reports.

SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models

You Won Lee, S. Heo, S. Lim, 2021, Clinical & translational immunology.

3-Oxoacid CoA transferase 1 as a therapeutic target gene for cisplatin-resistant ovarian cancer.

San-Duk Yang, So-Hee Ahn, Jong-Il Kim, 2017, Oncology letters.